Expanding Orthopedics Inc. Granted a New US Patent for Its Unique 3D Expandable Cage

Monday, November 14, 2016 Corporate News J E 4
14th US patent received by EOI, reinforces its position as an innovation leader in spinal expandable devices

OR AKIVA, Israel, November 14, 2016 /PRNewswire/ --

Expanding Orthopedics Inc. (EOI), a privately held medical device company focused on developing and commercializing innovative expandable devices for spine surgery, is excited to announce that it has been granted its 14th US Patent, covering its unique 3D expandable cage technology integrated in the FLXfit™."

Dr. Mark M. Levy, an orthopedic surgeon, CTO and founder of EOI says that, "This new patent recognizes the unique innovation of our 3D expandable cage, the FLXfit™." He explains that, "This patent refers to the multiple segments design with its articulation mechanism and the unique angular expansion for dial-in lordosis correction, conforming to the patient's anatomy and level treated."

Mr. Ofer Bokobza, EOI's CEO, commented, "This new patent grant is an important addition to our broad IP portfolio, demonstrating our continuous commitment to innovation and our ability to develop state-of-the-art devices addressing unmet clinical designed to improve patients' outcome". He concludes that, "We are working diligently on a rich product pipeline with unique IP which will reinforce our position as a fast growing expandable devices' spine company."

About Expanding Orthopedics Inc. 

Expanding Orthopedics Inc. (EOI) is medical device company developing and marketing innovative products designed to address unmet clinical needs for spine care and improve long-term patients' outcome. The Company is spearheaded by seasoned management team, and is backed by prominent spine surgeons. EOI owns a broad patent portfolio around anatomically fit, expandable devices for enhanced stability through a minimally invasive approach.

Contact info: David Elkaim, VP Marketing and Sales E-mail: Phone: +1-347-321-9683

SOURCE Expanding Orthopedics Inc. (EOI)



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
MIHI Wholly Owned Subsidiary “BKare Diagnostics, I...
Merck KGaA, Darmstadt, Germany's Phase IIb ADDRESS...